Description
Tirzepatide is well-known in research concerning type 2 diabetes and obesity. It operates as a dual agonist for GIP and GLP-1 receptors, which means it addresses two different pathways to promote weight loss and enhance blood sugar control.
“These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”
DISCLAIMER
For research purposes solely, we are unable to offer protocols for personal or human applications. Kindly refrain from making such requests.
Product Usage Notice: This item is exclusively meant for research and laboratory testing. It is not suitable for consumption by humans or animals. Only licensed professionals should handle it. It is neither a medication, food item, nor cosmetic and must not be incorrectly portrayed.
Reviews
There are no reviews yet.